Pfizer Q3: The Street Is Pricing In Too Much Deceleration For This 5.7% Yield
Pfizer delivered Q3 2026 revenue of $16.58B and adjusted EPS of $0.87, beating consensus and raising full-year guidance for the second time. I rate PFE stock as Buy.
BTC-1.12%
ETH-1.07%
SOL-1.91%
USDC-0.03%
XRP-2.05%
HYPE-6.95%
SUI-3.98%
DOGE-2.19%BTC-1.12%ETH-1.07%SOL-1.91%USDC-0.03%XRP-2.05%HYPE-6.95%SUI-3.98%DOGE-2.19%BTC-1.12%ETH-1.07%SOL-1.91%USDC-0.03%XRP-2.05%HYPE-6.95%SUI-3.98%DOGE-2.19%BTC-1.12%ETH-1.07%SOL-1.91%USDC-0.03%XRP-2.05%HYPE-6.95%SUI-3.98%DOGE-2.19%
